Navigation Links
Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
Date:8/29/2007

d clinical research organizations, manufacturers and consultants; and protecting the intellectual property developed by or licensed to Memory Pharmaceuticals. These and other risks are described in greater detail in Memory Pharmaceuticals' filings with the Securities and Exchange Commission. Memory Pharmaceuticals may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Memory Pharmaceuticals disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.


'/>"/>
SOURCE Memory Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 AARP Foundation today announced ... support older adults suffering from the severe cold weather ... its members are committed to helping those in need; ... AARP Foundation will match dollar-for-dollar contributions up to $250,000, ... matching program will be administered through AARP Foundation. ...
(Date:1/15/2014)... -- Shire plc (LSE: SHP, NASDAQ: ... Fair Trading (OFT) approval condition to the announced tender offer ... VPHM).   As a result of the waiver, ... Shire expects to complete the tender offer on January 24, ... satisfaction of all of the remaining conditions to the tender ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014 /PRNewswire/ ... such as MRSA, C. difficile and TB in ambulances and ... manufactured by MRSA-UV is now being used by rescue personnel ... prevent EMS paramedics and transport patients from coming in contact ... Fire Rescue is the first in the nation to ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
(Date:4/14/2014)... Ford Hospital reached a medical milestone April 3, ... a novel way to access the heart. , ... United States performing the unique procedure called transcaval ... connecting major blood vessels. , Northern Michigan resident ... procedure on July 3, 2013 when traditional valve ...
(Date:4/14/2014)... shows that moderate to severe obstructive sleep apnea is ... and death. , Results of the 20-year follow-up study ... apnea were four times more likely to die (hazard ... have a stroke (HR = 3.7), three times more ... 2.5 times more likely to develop cancer. Results were ...
(Date:4/14/2014)... DALLAS April 14, 2014 Popular web information ... people to read and doesn,t address the appropriate risks ... Southwestern Medical Center gastroenterologists suggests. , In a review ... patient education materials for colorectal cancer screening were written ... the sites failed to address key risks, as well ...
(Date:4/14/2014)... Ohio A new study identifies a molecule that ... suggests that the molecule could be an important target ... tumor progression. , The study of microRNA-135b (miR-135b) in ... the journal Cancer Cell and was led ... Center Arthur G. James Cancer Hospital and Richard ...
(Date:4/14/2014)... have unearthed still more evidence that antibiotics can ... print in the journal Antimicrobial Agents and ... treatment gained weight and had significant changes in ... by Didier Raoult, of Aix-Marseille University, Marseille, France, ... with doxycycline and hydroxychloroquine for Q fever, and ...
Breaking Medicine News(10 mins):Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Study identifies a likely key driver of colorectal cancer development and progression 2Health News:Long-term antibiotic treatment for Q fever causes weight gain 2
... was $ 0.28 per share ... ... Oct. 11 Herley Industries,Inc. (Nasdaq: HRLY ) today reported its financial results for ... quarter of 2007 was $3.8 million or $.28,per share, as compared to $713,000 or $.05 ...
... a simple tool that can improve the effectiveness of ... result in dramatic improvements in health and safety. , ... with color images of the medication to be taken ... in a patient,s native language if the patient does ...
... law firm of Kohn, Swift &,Graf, P.C. announces that ... Corporation ("Pall" or the "Company") (NYSE: PLL ).,The ... the Eastern,District of New York, seeks damages for violations ... purchased Pall securities between April,20, 2007 and August 8, ...
... 11, 2007 Cancer researchers have long worked to ... of therapies designed to stop the production of testosterone ... research has now detected that androgen-synthesizing proteins are present ... develop the capacity to produce their own androgens. ...
... protein previously implicated in prostate and breast cancer development ... pancreatic cancer. Researchers at the Kimmel Cancer Center at ... which normally applies the brakes on a cancer-causing ... pancreatic cancer. Though the work is preliminary, the scientists ...
... (Nasdaq: ALXN ), today announced that the Company ... Thursday, October 25, 2007,at 10:00 a.m. Eastern Time (ET), ... the third quarter ended September 30, 2007. Alexion,anticipates releasing ... 25, 2007. To participate in this conference call, ...
Cached Medicine News:Health News:Herley Reports 4th Quarter and Year-End Results 2Health News:Herley Reports 4th Quarter and Year-End Results 3Health News:Herley Reports 4th Quarter and Year-End Results 4Health News:Herley Reports 4th Quarter and Year-End Results 5Health News:Herley Reports 4th Quarter and Year-End Results 6Health News:Herley Reports 4th Quarter and Year-End Results 7Health News:Herley Reports 4th Quarter and Year-End Results 8Health News:Herley Reports 4th Quarter and Year-End Results 9Health News:Herley Reports 4th Quarter and Year-End Results 10Health News:Herley Reports 4th Quarter and Year-End Results 11Health News:Improving doctor-patient communication yields significant health benefits 2Health News:Improving doctor-patient communication yields significant health benefits 3Health News:Improving doctor-patient communication yields significant health benefits 4Health News:Kohn, Swift & Graf, P.C. Announces Commencement of Lawsuit Against Pall Corporation-PLL 2Health News:Kohn, Swift & Graf, P.C. Announces Commencement of Lawsuit Against Pall Corporation-PLL 3Health News:New research may show why some prostate cancer recurs after treatment 2Health News:New research may show why some prostate cancer recurs after treatment 3Health News:Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer 2
... Sun Med TruFlow™ Oxygen flowmeter with a ... warranty covering calibration and manufacturing defects. A ... meet most needs. Also available with all ... power take-off and double unit configurations. Our ...
... series of time-tested Timeter® Classic Flowmeters demonstrates ... care providers and patients alike. You can ... see it in the craftsmanship. You can ... year. Every Timeter® Classic Flowmeter is hand-crafted ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: